Updated:
BIOS Research
BIOS Research was founded with a focus on systematic investing driven by computational biology and machine learning.
BIOS Research
BIOS Research was founded with a focus on systematic investing driven by computational biology and machine learning. The firm applies models inspired by biological systems to financial data, a differentiation from traditional quant approaches. Its team includes scientists and researchers with backgrounds in computational biology and finance. The firm employs a multi-asset strategy, investing across equities, fixed income, and commodities. BIOS Research uses proprietary algorithms to analyze market data and generate signals. Known positions are not public, as the firm does not disclose specific holdings. The investment process is entirely systematic and research-driven. Team size and deployment levels are not disclosed publicly. BIOS Research has not announced any recent operational events or additional vehicles. The firm maintains a lean structure focused on research and development. BIOS Research's structural differentiator is its integration of biological modeling into quantitative finance. This approach sets it apart from purely statistical quant funds. The firm's governance and succession plans remain private.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
Who leads investment decisions at BIOS Research?
The leadership team at BIOS Research is not publicly named. The firm operates with a research-driven structure and does not disclose individual managers or principals (per public record).
How does BIOS Research source proprietary deal flow?
BIOS Research generates investment signals through proprietary algorithms that model biological systems. The firm does not rely on traditional deal flow channels or external sourcing (per the firm's official communications).
Is BIOS Research structured as a family office or investment firm?
BIOS Research is structured as a quantitative asset manager, not a family office. It functions as a systematic investment firm with a focus on computational biology and machine learning (per public record).
What investment stages does BIOS Research target?
BIOS Research invests across liquid markets including equities, fixed income, and commodities. The firm uses systematic strategies without a specific stage focus, as it trades in public markets (per the firm's official communications).
Which sectors does BIOS Research explicitly avoid?
BIOS Research does not publicly disclose any sectors it avoids. The quantitative nature of the firm suggests it trades broadly across asset classes without sector restrictions (per public record).
Does BIOS Research participate in fund commitments or only direct deals?
BIOS Research is a direct investor in liquid markets through its own systematic strategies. There is no public record of the firm committing capital to external fund managers (per public record).
How is BIOS Research related to other investment vehicles?
BIOS Research operates as a standalone entity. No public information links it to affiliated investment vehicles or parent organizations (per public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: